Tobacco firms' fake comments helped sink FDA menthol ban, study finds
A new study in JAMA Network Open finds that 97% of public comments opposing the FDA's proposed menthol cigarette ban were form letters, many generated by the tobacco industry.
Clinical AI, drug discovery, devices, and regulatory approvals.
A new study in JAMA Network Open finds that 97% of public comments opposing the FDA's proposed menthol cigarette ban were form letters, many generated by the tobacco industry.
An opinion essay argues that Heidi Overton, if confirmed as FDA commissioner, would use the agency to restrict mifepristone despite its safety record.
AI tools for nurses are moving from ambient charting into broader support, though fragmentation remains a key concern.
The appointment brings clinical development experience from Coherus to Rakuten Medical's oncology pipeline.
A new analysis estimates the autism-linked genetic disorder affects about 1 in 7,300 people, suggesting thousands of cases in the U.S. go undiagnosed.
A Nature Food analysis of 10 years of U.S. product launches finds most items with health claims fail nutritional benchmarks.
A health news roundup covers a worsening measles outbreak, a Class I drug recall, and other unrelated developments.
A prospective study finds both uterine-sparing procedures produce durable, comparable improvements in symptoms and quality of life.
A new RazorMetrics survey shows that high prescription prices push extra work onto physicians, not just patients.
The nursing honor society's removal of its CEO underscores unresolved questions about racism within the profession.
The singer's procedure highlights how catheter ablation, especially with newer pulsed field technology, is evolving as a first-line treatment for atrial fibrillation.
A Finnish observational study finds that maternal Tdap vaccination during pregnancy lowers preschoolers' antibody levels after primary DTaP, but the age-4 booster brings them back to normal.
A small trial shows that removing CD33 from donor stem cells lets CD33-targeting drugs attack cancer without wiping out the transplanted blood system.
A new workgroup aims to standardize measles death counts, but its launch follows a controversial change to CDC reporting.
A new AACR report credits smoking reductions and treatment advances for averting nearly 5 million cancer deaths, while warning that funding cuts threaten further progress.
ADARx becomes the first RNAi-focused biotech to price a U.S. IPO in over a decade, signaling renewed investor appetite for RNA medicines.
The new head of the government's autism project brings a background in military tech and children's media to improving diagnosis and care.
A U.N.-backed program has licensed 11 manufacturers to produce generic versions of Roche's flu drug Xofluza for 129 low- and middle-income countries.